Omega - 3 Fish oil in Rockledge, Florida

https://www.lastarzawellness.com

Omega - 3 Fish Oil has been a popular nutritional supplement for years. Some major benefits include decreasing inflammation, skin and hair health, better concentration, fetal eye and brain development, and supportive research shows it may reduce risk of coronary heart disease. A quality fish oil should contain a high DHA/EPA ratio. Here in our office we carry standard process that has a 2:1 ratio of DHA/EPA.  

Here are some studies provided by standard process

1. Balch P.A. 2010. Prescription for Nutritional Healing. 5th ed. Garden City Park, NY: Avery Publishing Group.: 51-52.
2. Covington M.B. 2004. Omega-3 fatty acids. American Family Physician. 70(1):133-140.
3. Enig M.G. 2000. Know Your Fats. Silver Spring, MD: Bethesda Press: 108-109, 138, 206-207.
4. Khan F., et al. 2003. The effects of dietary fatty acid supplementation on endothelial function and vascular tone in healthy subjects. Cardiovascular Research. 59 (4):955-962.
5. Maki K.C., et al. 2005. Lipid responses to a dietary docosahexaenoic acid supplement in men and women with below average levels of high density lipoprotein cholesterol. Journal of the American College of Nutrition. 24(3):189-199.
6. Meng L. P., et al. 2005. Relationship between maternal DHA intake and DHA status and development of fetus and infant. Wei Sheng Yan Jiu 34(2):231-233.
7. Mihrshahi S., et al. 2004. Pediatric Allergy and Immunology. 15(6):517-522.
8. O’Toole, M.T., ed.. 1998. Mosby’s Medical, Nursing, and Health Professions. 9th ed. St. Louis, MO: Mosby.
9. Putadechakum S., et al. 2005. Journal of the Medical Association of Thailand. 88(2):181-6.
10. Smithers L.G., et al. 2004. Asia Pacific Journal of Clinical Nutrition. 13 (Suppl):S50.
11. Troxell H., et al. 2005. Omega-3 for Baby and Me: Material Development for a WIC Intervention to Increase DHA Intake during Pregnancy. Matern Child Health Journal. (2):189-197.
12. Wilkinson P., et al. 2005. Influence of alpha-linolenic acid and fish-oil on markers of cardiovascular risk in subjects with an atherogenic lipoprotein phenotype. Atherosclerosis. 181(1):115-124.